Answers are grounded in this paper and cite their sources.
BACKGROUNDAlström syndrome (AS) is an ultra-rare autosomal recessive ciliopathy caused by pathogenic ALMS1 variants.Hepatic involvement may progress silently from biochemical abnormalities or steatosis to cirrhosis and liver failure, but its clinical course and relationship with metabolic dysfunction remain poorly characterized.We describe advanced liver disease in an affected adult and contextualize the case using published data from Chinese patients.CASE SUMMARY A 40-year-old Chinese man with lifelong visual impairment, childhood hepatomegaly, short stature, type 2 diabetes mellitus, hypertension, and hyperuricemia presented with abdominal distension and massive ascites.Elastography and imaging supported cirrhosis with portal hypertension; endoscopy showed varices, and liver biopsy revealed marked fibrosis.Whole-exome sequencing identified compound heterozygous nonsense variants in ALMS1, confirming AS.He received diuretics, albumin, therapeutic paracentesis, and subsequently underwent transjugular intrahepatic portosystemic shunt placement with coil embolization of esophagogastric varices for recurrent ascites.He developed grade IV hepatic encephalopathy after the procedure and died following multiorgan failure one month later.Published reports covering 305 Chinese patients documented liver abnormalities in 117 of 205 patients with evaluable hepatic data.Among 35 patients with hepatic involvement in a detailed subgroup, 24 had at least three metabolic abnormalities.No clear relationship between genotype and hepatic severity was identified.CONCLUSION 4 / 40 AS may involve clinically silent, progressive liver disease; early diagnosis and longitudinal fibrosis surveillance are essential.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: